Trigger: user thesis in session ("AI-driven + lab-automation biotech will boom once the IPO landscape clears this year; Lila is private, Ginkgo/DNA is a terrible stock — who are the public ones, and do we have an active system investigating this and the CROs/suppliers/Thermo landscape?"). Answer to the coverage question was no — whitespace. User chose "full perspective + watchlist" build.

What landed:

• biotech-capital-cycle watchlist, 24 names (RXRX SDGR TEM ABSI CDXS DNA / TMO DHR A RVTY WAT MTD BRKR ILMN TXG PACB TWST RGEN AVTR / IQV MEDP CRL ICLR FTRE), fetched + precomputed + verify:watchlist-tickers clean (24/24, no null-info).
• README (thesis, 4-layer landscape, code-computed tape table, best risk/reward, watch-fors) + this log.
• ACTIVE.json entry: status active, priority medium, paradigm cycle, 7 key_tickers (TMO/DHR/IQV/MEDP/RGEN/TWST/SDGR).

Paradigm = cycle (not macro): the load-bearing driver is the biotech funding/IPO capital cycle, not a one-shot event. The whole complex (L1 AI-bio platforms / L3 tools+consumables / L4 CROs) sells to biotech and re-rates with biotech funding.

Cross-link, not fold-in: shares the IPO-window/liquidity driver with spacex-ipo-liquidity-event but with opposite sign — SpaceX drains liquidity at the June 12 debut; a healthy biotech issuance regime later in the year returns liquidity to risk assets. Sibling lanes under the conceptual "AI mega-IPO supercycle" parent frame. Did NOT set a formal parent field — the parent is a frame, not a registered perspective; avoided a dangling reference.

The load-bearing, disciplined finding (and it flipped the user's premise): the user assumed "looks like it sucks right now" = pre-catalyst/early. The 2026-06-04 tape says the rotation is already underway and bifurcated. Mid-cap tools + CROs are running hot (RSI 70–82: BRKR/TXG/TWST/ICLR/FTRE/A near 52wk highs); the laggards are specifically the mega-cap anchors the user knows/owns (TMO −6% 3m, DHR −9%, MTD −8%, MEDP −2%) plus the un-re-rated AI-bio platforms (RXRX/TEM/DNA, −47 to −49% off highs). The "it sucks" read is a holding-selection artifact — the user owns the laggard (TMO) and a winner they may not have clocked (TWST +57% 3m). So the perspective opens NOT as "pre-catalyst monitoring lane" but as "rotation in progress; the optionality is in the laggard quality + the app-layer, not the extended mid-caps."

Discipline carried: all RSI/returns are code-computed precompute (price-truth), not prose math. Company quality reads (revenue model, moat, cash burn) are structural, not price claims. The parabolic movers (BRKR +64%/TXG +57% 30d) are explicitly flagged as needing a single-name catalyst check before being treated as clean cycle expressions — they may be M&A/activist stories riding the theme.

Capacity: this is the 11th active perspective (ACTIVE.json now holds 11 active + 1 monitoring = gold-crash, downgraded 2026-06-03), well over the editorial 8 soft cap. Opened without a retire — consistent with the same-day livestock precedent (user-directed adds over cap). Capacity hygiene is a deferred editorial call; natural future offsets remain spacex-ipo-liquidity-event (decays after 2026-06-12) and gulf-infrastructure-strike (relevance_until 2026-09-30). Flag surfaced to the user, not silently actioned.

Deploy: none — local staging only (no prod deploy requested; consistent with current "UI being worked on" posture).

Open / carried follow-ups:

• Catalyst-verify the BRKR + TXG parabolas (M&A / activist / guidance?) before treating as cycle proof.
• CRO book-to-bill / bookings on next prints (IQV/MEDP/ICLR/CRL) — the cleanest cycle-turn confirmation.
• Deep-dive candidate: the cleanest laggard expression (MEDP or RGEN) + SDGR (the software-moat AI-bio platform) if conviction firms. Offered, not auto-built.
• Confirmation gate: rotation is ratified when TMO/DHR/MEDP put in positive 3m + RSI > 60 together (mega-cap money joining the mid-cap front-run).